Correlation Engine 2.0
Clear Search sequence regions


  • cytokines (1)
  • factor (2)
  • GSK3 (12)
  • GSK3β (3)
  • homeostasis (1)
  • isoform (1)
  • mice (1)
  • microglia (3)
  • NF E2 (2)
  • NF kappa B (2)
  • Nrf2 (7)
  • nuclear factor kappa b (2)
  • paralogs (2)
  • redox (1)
  • Sizes of these terms reflect their relevance to your search.

    Glycogen synthase kinase 3 (GSK3) is associated with the proinflammatory phenotype of microglia and has been shown to act in concert with nuclear factor kappa B (NF-κB). GSK3 is also a suppressor of nuclear factor erythroid 2-related factor 2 (Nrf2), the principal regulator of redox homeostasis. Agreeing with the oxidative paradigm of aging, Nrf2 is often deregulated in parainflammatory and neurodegenerative diseases. In this study, we aimed to explore a multimodal disease-modifying utility of GSK3 inhibition, beyond neuronal proteopathologies. Furthermore, we aimed to underscore the difference in therapeutic value between the two GSK3 paralogs by isoform-selective chemical inhibition. The anti-inflammatory effects of paralog-selective GSK3 inhibitors were evaluated as a function of the reductive capacity of each to mitigate LPS-induced activation of SIM-A9 microglia. The Griess method was employed to detect the nitrate-lowering capacity of selective GSK3 inhibition. Real-time PCR was used to assess post-treatment expression levels of pro-inflammatory markers and antioxidant genes; pro-inflammatory cytokines were assayed by ELISA. Nuclear lysates of treated cells were examined for Nrf2 and NF-κB accumulation by immunoblotting. Finally, to infer whether the counter-inflammatory activity of GSK3 inhibition was Nrf2-dependent, DsiRNA-mediated knockdown of Nrf2 was attempted. Results from our experiments reveal a superior anti-inflammatory and anti-oxidative efficacy for GSK3β-selective inhibition, compared to GSK3α-selective and non-selective pan-inhibition; hence, use of selective GSK3β inhibitors is likely to be more propitious than non-selective dual inhibitors administered at comparable doses. Moreover, our results suggest that the anti-inflammatory effects of GSK3 inhibition are not Nrf2 dependent. © 2022. The Author(s).

    Citation

    Mohamed H Yousef, Mohamed Salama, Hassan A N El-Fawal, Anwar Abdelnaser. Selective GSK3β Inhibition Mediates an Nrf2-Independent Anti-inflammatory Microglial Response. Molecular neurobiology. 2022 Sep;59(9):5591-5611

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35739410

    View Full Text